Latest News

July 08, 2000
A multicenter U.S. study has found that the addition of the immune stimulator interleukin-2 (IL-2) to antiretroviral therapy (ART) appears to improve immunologic function in patients with an intermediate stage of HIV infection and may augment the anti-HIV activity of potent antiretroviral agents. Patients who took IL-2 in addition to their regular therapy had increases in CD4 cell counts—a type of white blood cell that helps fight HIV—and decreases in the amount of virus detectable in their blood.
May 04, 2000
UC San Francisco researchers have discovered a region in the telomerase enzyme that they say could prove to be a target for killing cancer cells and regenerating damaged cells, and could also lead to a possible target for attacking HIV.
March 16, 2000
After a sold out session last fall, the UCSF Mini Medical School returns on April 5 for a spring semester of classes for the general public.  The spring 2000 sessions, entitled “Health Sense from Health Science,” will feature talks on the safety and efficacy of alternative and complementary therapies, the effects of human touch on health and development, and the potentially dangerous interactions of drugs and herbal remedies. (See attached schedule for a complete list of course topics.)
March 14, 2000
In a finding that reveals a link between alcoholism and drug addiction, scientists have discovered that a key step leading to alcohol addiction can be blocked by preventing alcohol from gaining access to nerves in the brain involved in learning.
March 14, 2000
Researchers led by UCSF scientists are reporting that an experimental pain drug known as a kappa-opioid brings pain relief to female rats but not males, a finding that adds weight to a recent UCSF clinical finding, and highlights, they say, the need to evaluate drugs by gender. Traditionally, kappa-opioids have been dismissed as ineffective analgesics in humans, though the drugs have shown mixed results in animal studies, depending on how they have been administered.
March 13, 2000
Bones that refuse to heal may one day be set straight by a drug that stimulates the growth of new blood vessels, according to new research from the University of California, San Francisco.  So far, however, the growth factor drug has been tested only in mice, and it could be years before it is used in hospitals. These results were presented at this week’s annual meeting of the Orthopaedic Research Society, in Orlando, Florida.
March 13, 2000
All four UC San Francisco health science schools ranked among the top four comparable institutions in the country in the 1999 fiscal year competition for federal research dollars from the National Institutes of Health (NIH), according to the most recent data obtained from the agency. The UCSF schools received a total of $227.5 million in research grants, training grants, contracts and fellowships during the 1999 federal fiscal year, $2.8 million more than during the 1998 fiscal year.
March 13, 2000
A new agreement between UC San Francisco and a consortium of community-based agencies establishes a comprehensive system to promote local hiring on all major campus construction projects, including UCSF Mission Bay.
March 09, 2000
A genetic test to help pathologists identify melanoma, the most common type of skin cancer, has been developed by researchers at University of California, San Francisco, and may be available to pathology labs within a year.  The test, which detects chromosomal abnormalities that characterize cancerous skin cells, was described here, today (March 9), at the annual meeting of the International Society of Dermatopathology.
March 08, 2000
A new network has been formed by linking the University of California, San Francisco and four other academic medical centers to accelerate progress on serious and life-threatening pediatric diseases.